Take Solutions won a large long-period deal from one of its top clients.
The deal contract is valid till 2024 with total deal size adding up to around USD 160 million, said Vice Chairman & Managing Director, Srinivasan HR. He expects a compounded annual growth rate of 15 percent.However, he clarified that there are covenants. Performance matrix is attached to the deal but since the company has an excellent performance track record, they are confident of executing the deal.
He is not only confident of a 25 percent organic growth in FY17 but also of sustaining similar growth for the next three years. He also does not rule out inorganic growth.
On the margin front, he said, margins for the lifescience business are upwards of 25 percent and that there is an opportunity to expand the margins by 1.5-2 percent over the next two years, he said.For the full interview, watch video
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!